Literature DB >> 6406629

Microscopic measurements of platelet aggregation reveal a low ADP-dependent process distinct from turbidometrically measured aggregation.

M M Frojmovic, J G Milton, A Duchastel.   

Abstract

Platelet aggregation measured from the decrease in the number of nonaggregated platelets (PA) is compared with that measured from the increase in %T (TA) after ADP addition to a stirred platelet suspension. A number of properties distinguish PA from TA. Half-maximal extent of PA, measured at 3 or 10 sec after ADP addition is attained at significantly lower ADP concentrations ([ADP]) than for TA (velocity and extent), and in particular at [ADP] equal to or less than that required for shape change. PA appears minimally refractory to ADP under conditions causing maximal refractoriness of TA. Examination of the effect of three inhibitors of platelet aggregation acting on extracellular ionized calcium (EDTA) and on platelet adenylate cyclase (PGE1) and phosphodiesterase (anagrelide; BL-4162A) indicates that PA is generally less sensitive to these inhibitors than TA but, of greater significance, that PA and TA reveal aggregation processes with differing ADP sensitivities. It is suggested that these differences reflect different processes determining the strength of interplatelet interactions. Conventional aggregometry is insensitive for measuring the low ADP-dependent aggregation process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406629

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets.

Authors:  M E Hensler; M Frojmovic; R G Taylor; R R Hantgan; J C Lewis
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Long-range interactions in mammalian platelet aggregation. I. Evidence from kinetic studies in brownian diffusion.

Authors:  K Longmire; M Frojmovic
Journal:  Biophys J       Date:  1990-08       Impact factor: 4.033

3.  Long-range interactions in mammalian platelet aggregation. II. The role of platelet pseudopod number and length.

Authors:  M Frojmovic; K Longmire; T G van de Ven
Journal:  Biophys J       Date:  1990-08       Impact factor: 4.033

4.  Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).

Authors:  J G Milton; M M Frojmovic; S S Tang; J G White
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

5.  Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. II. Platelet size-dependent subpopulations.

Authors:  M Frojmovic; T Wong
Journal:  Biophys J       Date:  1991-04       Impact factor: 4.033

6.  Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption.

Authors:  A J Verhoeven; M E Mommersteeg; J W Akkerman
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

7.  PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.

Authors:  E Kloprogge; P Hasselaar; J W Akkerman
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

8.  Role of thrombospondin in platelet aggregation.

Authors:  L L Leung
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.

Authors:  M M Frojmovic; R F Mooney; T Wong
Journal:  Biophys J       Date:  1994-11       Impact factor: 4.033

10.  Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.

Authors:  E Kloprogge; J W Akkerman
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.